MSD awaits 20 potential launches and 80 late-stage readouts across its pipeline, which it believes will double $35bn ...

Newly diagnosed patients with KRAS G12C-mutant advanced or metastatic nonsquamous NSCLC will be enrolled in the trial.

MSD's cancer immunotherapy Keytruda will soon be available as a subcutaneous injection that does away with the need to visit an infusion clinic. Keytruda Qlex (pembrolizumab and berahyaluronidase alfa ...

MSD is a company that is ‘serious about science.’ In 2024, its global research and development investment reached $17.9 ...

MSD's plan to reduce its headcount by around 6,000, first revealed a couple of weeks ago, looks like it will start at its headquarters in Rahway, New Jersey. Confirmation of that has come in the form ...

MSD in the Philippines’ “Di Mo DeCERV!” campaign has been awarded Bronze in the Advocacy category at this year’s ICE Awards, ...

LOUISVILLE, Ky. — Louisville MSD is moving its main office to the Park Hill neighborhood. What was a Clariant chemical factory will be the utility provider's new headquarters. The new location for is ...